LINC00106/RPS19BP1/p53 axis promotes the proliferation and migration of human prostate cancer cells

Background Prostate cancer (PCa) is among the most prevalent cancers in males with high biochemical recurrence risk. LINC00106 contributes to the carcinogenesis of Hepatocellular carcinoma (HCC). However, it is unclear how it affects PCa advancement. Here, we studied LINC00106’s effects on PCa cells...

Full description

Bibliographic Details
Main Authors: Lingxiang Lu, Zhen Tian, Jicheng Lu, Minjun Jiang, Jianchun Chen, Shuai Guo, Yuhua Huang
Format: Article
Language:English
Published: PeerJ Inc. 2023-05-01
Series:PeerJ
Subjects:
Online Access:https://peerj.com/articles/15232.pdf
_version_ 1827600145021140992
author Lingxiang Lu
Zhen Tian
Jicheng Lu
Minjun Jiang
Jianchun Chen
Shuai Guo
Yuhua Huang
author_facet Lingxiang Lu
Zhen Tian
Jicheng Lu
Minjun Jiang
Jianchun Chen
Shuai Guo
Yuhua Huang
author_sort Lingxiang Lu
collection DOAJ
description Background Prostate cancer (PCa) is among the most prevalent cancers in males with high biochemical recurrence risk. LINC00106 contributes to the carcinogenesis of Hepatocellular carcinoma (HCC). However, it is unclear how it affects PCa advancement. Here, we studied LINC00106’s effects on PCa cells’ ability to proliferate, invade, and metastasize. Methods The data of LINC00106 from The Cancer Genome Atlas (TCGA) in human PCa tissues were analyzed using TANRIC and survival analysis. In order to determine the expression levels of genes and proteins, we also performed reverse transcription-quantitative PCR and western blot analysis. The migration, invasion, colony formation, and proliferation (CCK-8) of PCa cells with LINC00106 knockdown were investigated. The impact of LINC00106 on cell proliferation and invasion was also analyzed in mice. LncRNA prediction software catRAPID omics v2.1 (catRAPID omics v2.0 (tartaglialab.com)) was used to predict proteins that might interact with LINC00106. The interactions were verified via RNA immunoprecipitation and RNA pull-down assays and finally, the interaction between LINC00106 and its target protein and the p53 signaling pathway was studied using a dual-luciferase reporter assay. Results In PCa, LINC00106 was over-expressed in comparison to normal tissues, and it was linked to an unfavorableprognosis. In vitro and in vivo analyses showed that downregulating LINC00106 decreased PCa cells’ability to proliferate and migrate. A common regulatory axis generated by LINC00106 and RPS19BP1 prevents p53 activity. Conclusion Our experimental data indicate that LINC00106 functions as an oncogene in the onset of PCa, and the LINC00106/RPS19BP1/P53 axis canserve as a novel therapeutic target for PCa treatment.
first_indexed 2024-03-09T04:29:48Z
format Article
id doaj.art-6cc04fd5f1f8450cb982c9c7bd546033
institution Directory Open Access Journal
issn 2167-8359
language English
last_indexed 2024-03-09T04:29:48Z
publishDate 2023-05-01
publisher PeerJ Inc.
record_format Article
series PeerJ
spelling doaj.art-6cc04fd5f1f8450cb982c9c7bd5460332023-12-03T13:36:33ZengPeerJ Inc.PeerJ2167-83592023-05-0111e1523210.7717/peerj.15232LINC00106/RPS19BP1/p53 axis promotes the proliferation and migration of human prostate cancer cellsLingxiang Lu0Zhen Tian1Jicheng Lu2Minjun Jiang3Jianchun Chen4Shuai Guo5Yuhua Huang6Department of Urinary Surgery, Suzhou Ninth People’s Hospital, Soochow University, Suzhou, Jiangsu, ChinaDepartment of Urinary Surgery, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, ChinaOncology Department, Suzhou Ninth People’s Hospital, Soochow University, Suzhou, Jiangsu, ChinaDepartment of Urinary Surgery, Suzhou Ninth People’s Hospital, Soochow University, Suzhou, Jiangsu, ChinaDepartment of Urinary Surgery, Suzhou Ninth People’s Hospital, Soochow University, Suzhou, Jiangsu, ChinaDepartment of Urinary Surgery, Suzhou Ninth People’s Hospital, Soochow University, Suzhou, Jiangsu, ChinaDepartment of Urinary Surgery, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, ChinaBackground Prostate cancer (PCa) is among the most prevalent cancers in males with high biochemical recurrence risk. LINC00106 contributes to the carcinogenesis of Hepatocellular carcinoma (HCC). However, it is unclear how it affects PCa advancement. Here, we studied LINC00106’s effects on PCa cells’ ability to proliferate, invade, and metastasize. Methods The data of LINC00106 from The Cancer Genome Atlas (TCGA) in human PCa tissues were analyzed using TANRIC and survival analysis. In order to determine the expression levels of genes and proteins, we also performed reverse transcription-quantitative PCR and western blot analysis. The migration, invasion, colony formation, and proliferation (CCK-8) of PCa cells with LINC00106 knockdown were investigated. The impact of LINC00106 on cell proliferation and invasion was also analyzed in mice. LncRNA prediction software catRAPID omics v2.1 (catRAPID omics v2.0 (tartaglialab.com)) was used to predict proteins that might interact with LINC00106. The interactions were verified via RNA immunoprecipitation and RNA pull-down assays and finally, the interaction between LINC00106 and its target protein and the p53 signaling pathway was studied using a dual-luciferase reporter assay. Results In PCa, LINC00106 was over-expressed in comparison to normal tissues, and it was linked to an unfavorableprognosis. In vitro and in vivo analyses showed that downregulating LINC00106 decreased PCa cells’ability to proliferate and migrate. A common regulatory axis generated by LINC00106 and RPS19BP1 prevents p53 activity. Conclusion Our experimental data indicate that LINC00106 functions as an oncogene in the onset of PCa, and the LINC00106/RPS19BP1/P53 axis canserve as a novel therapeutic target for PCa treatment.https://peerj.com/articles/15232.pdfLINC00106Prostate cancerRPS19BP1p53
spellingShingle Lingxiang Lu
Zhen Tian
Jicheng Lu
Minjun Jiang
Jianchun Chen
Shuai Guo
Yuhua Huang
LINC00106/RPS19BP1/p53 axis promotes the proliferation and migration of human prostate cancer cells
PeerJ
LINC00106
Prostate cancer
RPS19BP1
p53
title LINC00106/RPS19BP1/p53 axis promotes the proliferation and migration of human prostate cancer cells
title_full LINC00106/RPS19BP1/p53 axis promotes the proliferation and migration of human prostate cancer cells
title_fullStr LINC00106/RPS19BP1/p53 axis promotes the proliferation and migration of human prostate cancer cells
title_full_unstemmed LINC00106/RPS19BP1/p53 axis promotes the proliferation and migration of human prostate cancer cells
title_short LINC00106/RPS19BP1/p53 axis promotes the proliferation and migration of human prostate cancer cells
title_sort linc00106 rps19bp1 p53 axis promotes the proliferation and migration of human prostate cancer cells
topic LINC00106
Prostate cancer
RPS19BP1
p53
url https://peerj.com/articles/15232.pdf
work_keys_str_mv AT lingxianglu linc00106rps19bp1p53axispromotestheproliferationandmigrationofhumanprostatecancercells
AT zhentian linc00106rps19bp1p53axispromotestheproliferationandmigrationofhumanprostatecancercells
AT jichenglu linc00106rps19bp1p53axispromotestheproliferationandmigrationofhumanprostatecancercells
AT minjunjiang linc00106rps19bp1p53axispromotestheproliferationandmigrationofhumanprostatecancercells
AT jianchunchen linc00106rps19bp1p53axispromotestheproliferationandmigrationofhumanprostatecancercells
AT shuaiguo linc00106rps19bp1p53axispromotestheproliferationandmigrationofhumanprostatecancercells
AT yuhuahuang linc00106rps19bp1p53axispromotestheproliferationandmigrationofhumanprostatecancercells